¿ì²¥³ÉÈËÍø

Michael B. Bober, MD

Genetics

Primary Office

¿ì²¥³ÉÈËÍø Children's Hospital, Delaware ¿ì²¥³ÉÈËÍø Children's Hospital, Delaware 1600 Rockland Road Wilmington, DE 19803 Appointment: (800) 416-4441

Get to Know Me

Dr. Michael B. Bober is a pediatric geneticist and an authority on skeletal dysplasias, brittle bone disease, primordial dwarfism and other genetic disorders of the skeleton. He is a frequent guest lecturer, accomplished author and consultant for numerous television networks, here and abroad.

Education & Training

Fellowship

  • Medical and Molecular Genetics - Johns Hopkins University Program, 2001

Residency

  • Pediatrics - Tulane University School of Medicine, 1998
  • Pediatrics - Tulane University School of Medicine, 2003
  • Medical Genetics - Johns Hopkins Hospital, 2000

Medical/Dental School

  • M.D. - Tulane University, 1996
  • PhD - Tulane University, 1996

Board Certifications

  • American Board of Pediatrics/Pediatrics - General
  • American Board of Medical Genetics and Genomics/Clinical Genetics and Genomics
  • American Board of Medical Genetics and Genomics/Clinical Molecular Genetics and Genomics

Awards & Recognition

  • 2014 Best Doctors in America
  • 2013 Best Doctors in America
  • 2012 Best Doctors in America
  • 2012 ¿ì²¥³ÉÈËÍø Physician Excellence Award in Scholarship
  • 2011 America’s Top Pediatricians
  • 2008 Patient’s Choice Award
  • 2007 America’s Top Pediatricians
  • 2009 Best Doctors in America
  • 2009 Patient’s Choice Award
  • 2008 2000 Outstanding Scientists 2008/2009
  • 2008 America’s Top Pediatricians
  • 2008 Best Doctors in America
  • 2011 Best Doctors in America
  • 2011 Patient’s Choice Award
  • 2010 America’s Top Pediatricians
  • 2010 Best Doctors in America
  • 2010 Patient’s Choice Award
  • 2009 America’s Top Pediatricians

Insurance Accepted

  • Aetna HMO
  • Aetna HMO/POS/PPO/EPO
  • Aetna PPO/POS/EPO
  • Amerihealth Caritas Delaware
  • Amerihealth Caritas Delaware - Delaware & Chester CTY ONLY
  • AMERIHEALTH CARITAS DELAWARE VIP NEXT
  • AvMed
  • Blue Cross and Blue Shield HMO
  • Blue Cross and Blue Shield Non HMO
  • Blue Cross Blue Shield Florida Blue Select
  • Carefirst MD Community Health Plan Mcaid
  • Cigna PPO/EPO/HMO/POS/OPEN ACCESS
  • Cigna/Great West HMO EPO POS
  • Cigna/Great West PPO
  • Community Care Plan Medicaid
  • Delaware First Health
  • Delaware Medicaid/Diamond State
  • Delaware Medicaid/Diamond State - Delaware & Chester CTY Sites ONLY
  • Delaware Medicare
  • Devon Health Services
  • Employers Health Network PPO
  • Evolutions Healthcare
  • Fidelis Care NJ Medicaid HMO
  • First Health Aetna PPO/EPO
  • First Health/Affordable PPO
  • Florida Community Care
  • Florida Medicaid
  • Florida Medicare
  • Geisinger Health Plan Commercial
  • Georgia Medicaid/Georgia Better Health/Peachcare
  • Global Medical Managment DE/PA
  • Health First Health Plans
  • Health Partners Medicaid/Kidz Partner HMO
  • Highmark Blue Cross Blue Shield of Delaware
  • Highmark Blue Cross Blue Shield of Delaware *PA Loc Contiguous to DE*
  • Highmark Blue Cross Blue Shield of Delaware *PA Loc NONContiguous to DE*
  • Highmark Blue Cross Blue Shield of Pennsylvania
  • Highmark Medicaid Health Options
  • Highmark Medicaid Health Options Delaware & Chester Counties ONLY
  • Horizon Blue Cross Blue Shield of New Jersey
  • HUMANA HEALTHY HORIZONS (FKA HUMANA MEDICAID)
  • Independance Blue Cross/Amerihealth/Keystone Health Plan
  • Insurance Administrators of America
  • INTEGRA Administrative Group (ClaimsBridge)
  • Keystone First Medicaid HMO
  • Lifetrac Transplant
  • Maryland Medicaid
  • Molina Healthcare Medicaid
  • Multiplan PPO
  • National Transplant (Humana)
  • New Jersey Medicaid
  • Olympus Managed Healthcare PPO ORL
  • Pennsylvania Medicaid
  • Prime Health Services PPO Specialty Florida
  • Priority Partners John Hopkins
  • Private Health Care Systems (PHCS)
  • Qualcare HMO/POS/PPO
  • Seminole Tribe of Florida
  • Simply Healthcare Healthy Kids
  • Simply Healthcare Medicaid HMO
  • Star Healthcare Network
  • Sunshine SMI/CMS 19 & 21
  • Sunshine State Health Plan Medicaid
  • Three Rivers Provider Network
  • Tricare/Humana Military Health Services/CHAMPVA
  • United Healthcare Commercial Products
  • United Healthcare Community Plan Medicaid
  • United Healthcare of the Mid-Atlantic
  • UPMC Medicaid/CHIP
  • US Family Health Plan
  • Volusia Health Network PPO/EPO
  • Wellpoint Maryland Medcaid

  • Skeletal Dysplasia

Medical Interests

  • Diagnosis and management of the various forms of microcephalic primordial dwarfism
  • Emerging medical treatments for skeletal dysplasias
  • The elucidation of the natural history of OI and skeletal dysplasias
  • The role of C-Naturietic Peptide in all skeletal dysplasias
  • Clinical management of rhizomelic chondrodysplasia punctata (RCDP)

  • Vosoritide Therapy in Children with Achondroplasia: Early Experience and Practical Considerations for Clinical Practice; Advances in Therapy; (2024).

  • The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review.; Orphanet journal of rare diseases; (2023).

  • RNU4atac-opathy; Unknown Source; (2023).

  • Route of Delivery Does Not Impact Postnatal Surgical Morbidity in Pregnancies Affected By Fetal Achondroplasia.; Genetics in medicine : official journal of the American College of Medical Genetics; (2023).

  • Tracheal Narrowing and Its Impact on Anesthesia Care in Patients With Morquio A (Mucopolysaccharidosis Type IVA): An Observational Study.; Anesthesia and analgesia; (2023).

  • Achondroplasia natural history study (CLARITY): 60-year experience in orthopedic surgery from four skeletal dysplasia centers.; Orphanet journal of rare diseases; (2023).

  • A qualitative exploration of patient perspectives on psychosocial burdens and positive factors in adults with osteogenesis imperfecta.; American journal of medical genetics. Part A; (2023).

  • Identification of potential non-invasive biomarkers in diastrophic dysplasia.; Bone; (2023).

  • Achondroplasia Natural History Study (CLARITY): 60-year experience with hydrocephalus in achondroplasia from four skeletal dysplasia centers.; Journal of neurosurgery. Pediatrics; (2023).

  • RAB1A haploinsufficiency phenocopies the 2p14-p15 microdeletion and is associated with impaired neuronal differentiation.; American journal of human genetics; (2023).

  • Once-weekly TransCon CNP (navepegritide) in children with achondroplasia (ACcomplisH): a phase 2, multicentre, randomised, double-blind, placebo-controlled, dose-escalation trial.; EClinicalMedicine; (2023).

  • Vosoritide therapy in children with achondroplasia aged 3-59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial.; The Lancet. Child & adolescent health; (2023).

  • Specific heterozygous variants in MGP lead to endoplasmic reticulum stress and cause spondyloepiphyseal dysplasia.; Nature communications; (2023).

  • Trends in Serum Cytokine Expression in Pediatric Skeletal Dysplasia; JBMR Plus; (2023).

  • Overlapping and Distinct Features of Cardiac Pathology in Inherited Human and Murine Ether Lipid Deficiency; International Journal of Molecular Sciences; (2023).

  • Immune Deficiency in Microcephalic Osteodysplastic Primordial Dwarfism Type I/III; Journal of Clinical Immunology; (2023).

  • Cranio-cervical abnormalities in moderate-to-severe osteogenesis imperfecta - Genotypic and phenotypic determinants.; Orthodontics & craniofacial research; (2023).

  • Microcephalic Osteodysplastic Primordial Dwarfism Type II; Unknown Source; (2022).

  • Multicenter Series of Deformity Correction Using Guided Growth in the Setting of Osteogenesis Imperfecta.; Journal of pediatric orthopedics; (2022).

  • Infigratinib in children with achondroplasia: the PROPEL and PROPEL 2 studies.; Therapeutic advances in musculoskeletal disease; (2022).

  • Collagen X Marker Levels are Decreased in Individuals with Achondroplasia.; Calcified tissue international; (2022).

  • Findings from the Morquio A Registry Study (MARS) after 6 years: Long-term outcomes of MPS IVA patients treated with elosulfase alfa.; Molecular genetics and metabolism; (2022).

  • A multicenter study to evaluate pain characteristics in osteogenesis imperfecta.; American journal of medical genetics. Part A; (2022).

  • Growth parameters in children with achondroplasia: A 7-year, prospective, multinational, observational study.; Genetics in medicine : official journal of the American College of Medical Genetics; (2022).

  • International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia.; Nature reviews. Endocrinology; (2021).

  • Achondroplasia Natural History Study (CLARITY): 60-year experience in cervicomedullary decompression in achondroplasia from four skeletal dysplasia centers.; Journal of neurosurgery. Pediatrics; (2021).

  • Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study.; Genetics in medicine : official journal of the American College of Medical Genetics; (2021).

  • Long-term vascular access for infants with moderate to severe osteogenesis imperfecta.; Pediatric surgery international; (2021).

  • Growth in Achondroplasia Including Stature, Weight, Weight-for-Height and Head Circumference from CLARITY: Achondroplasia Natural History Study— A Multi-Center Retrospective Cohort Study of Achondroplasia in the US; Unknown Source; (2021).

  • Otolaryngology Utilization in Patients With Achondroplasia: Results From the CLARITY Study.; The Laryngoscope; (2021).

  • Multidisciplinary Care of Neurosurgical Patients with Genetic Syndromes.; Neurosurgery clinics of North America; (2021).

  • Microcephalic osteodysplastic primordial dwarfism type II is associated with global vascular disease; Orphanet Journal of Rare Diseases; (2021).

  • Missing and unerupted teeth in osteogenesis imperfecta.; Bone; (2021).

  • Achondroplasia Natural History Study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States.; Genetics in medicine : official journal of the American College of Medical Genetics; (2021).

  • Osteogenesis imperfecta tooth level phenotype analysis: Cross-sectional study.; Bone; (2021).

  • Growth in achondroplasia including stature, weight, weight-for-height and head circumference from CLARITY: achondroplasia natural history study-a multi-center retrospective cohort study of achondroplasia in the US.; Orphanet journal of rare diseases; (2021).

  • Comprehensive pain management strategy for infants with moderate to severe osteogenesis imperfecta in the perinatal period; Paediatric and Neonatal Pain; (2021).

  • Alterations of a serum marker of collagen X in growing children with osteogenesis imperfecta.; Bone; (2021).

  • Persistent and Stable Growth Promoting Effects of Vosoritide in Children With Achondroplasia for up to 2 Years: Results From the Ongoing Phase 3 Extension Study; Journal of the Endocrine Society; (2021).

  • CLARITY: Co-occurrences in achondroplasia-craniosynostosis, seizures, and decreased risk of diabetes mellitus.; American journal of medical genetics. Part A; (2021).

  • Best practice guidelines in managing the craniofacial aspects of skeletal dysplasia.; Orphanet journal of rare diseases; (2021).

  • Best practice guidelines in managing the craniofacial aspects of skeletal dysplasia; Unknown Source; (2021).

  • Tracheal narrowing in children and adults with mucopolysaccharidosis type IVA: evaluation with computed tomography angiography.; Pediatric radiology; (2021).

  • Health-related quality of life in adults with osteogenesis imperfecta.; Clinical genetics; (2021).

  • Should We Stop Calling Thanatophoric Dysplasia a Lethal Condition? A Case Report of a Long-Term Survivor.; Palliative medicine reports; (2020).

  • SAT-LB18 A Randomized Controlled Trial of Vosoritide in Children With Achondroplasia; Journal of the Endocrine Society; (2020).

  • Best practice guidelines for management of spinal disorders in skeletal dysplasia; Unknown Source; (2020).

  • Best practice guidelines for management of spinal disorders in skeletal dysplasia.; Orphanet journal of rare diseases; (2020).

  • Malocclusion traits and oral health-related quality of life in children with osteogenesis imperfecta: A cross-sectional study.; Journal of the American Dental Association (1939); (2020).

  • Growth in individuals with Saul-Wilson syndrome.; American journal of medical genetics. Part A; (2020).

  • A Multicenter Study of Intramedullary Rodding in Osteogenesis Imperfecta. ; JB & JS open access; (2020).

  • Once-daily, subcutaneous vosoritide therapy in children with achondroplasia: a randomised, double-blind, phase 3, placebo-controlled, multicentre trial.; Lancet (London, England); (2020).

  • Case Report: Safety and Efficacy of Denosumab in Four Children With Noonan Syndrome With Multiple Giant Cell Lesions of the Jaw.; Frontiers in pediatrics; (2020).

  • Rhizomelic chondrodysplasia punctata morbidity and mortality, an update; American Journal of Medical Genetics Part A; (2020).

  • Cervical kyphosis: A predominant feature of patients with osteogenesis imperfecta type 5.; Bone reports; (2020).

  • Rhizomelic Chondrodysplasia Punctata Type 1; Unknown Source; (2020).

  • Defining the clinical phenotype of Saul-Wilson syndrome.; Genetics in medicine : official journal of the American College of Medical Genetics; (2020).

  • Best practice guidelines regarding diagnosis and management of patients with type II collagen disorders.; Genetics in medicine : official journal of the American College of Medical Genetics; (2019).

  • Assessing disease experience across the life span for individuals with osteogenesis imperfecta: challenges and opportunities for patient-reported outcomes (PROs) measurement: a pilot study.; Orphanet journal of rare diseases; (2019).

  • A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta.; JBMR plus; (2019).

  • Mobility in osteogenesis imperfecta: a multicenter North American study.; Genetics in medicine : official journal of the American College of Medical Genetics; (2019).

  • Biallelic variants in DNA2 cause microcephalic primordial dwarfism.; Human mutation; (2019).

  • Prevalence of mental health conditions and pain in adults with skeletal dysplasia; Quality of Life Research; (2019).

  • NOVEL <i>XRCC4</i> MUTATIONS IN AN INFANT WITH MICROCEPHALIC PRIMORDIAL DWARFISM, DILATED CARDIOMYOPATHY, SUBCLINICAL HYPOTHYROIDISM, AND EARLY DEATH: EXPANDING THE PHENOTYPE OF <i>XRCC4</i> MUTATIONS.; AACE clinical case reports; (2019).

  • New insights into minor splicing—a transcriptomic analysis of cells derived from TALS patients; RNA; (2019).

  • Pediatric Outcomes Data Collection Instrument is a Useful Patient-Reported Outcome Measure for Physical Function in Children with Osteogenesis Imperfecta.; Genetics in medicine : official journal of the American College of Medical Genetics; (2019).

  • Blood pressure in adults with short stature skeletal dysplasias.; American journal of medical genetics. Part A; (2019).

  • Hearing loss in individuals with osteogenesis imperfecta in North America: Results from a multicenter study.; American journal of medical genetics. Part A; (2019).

  • DNA Polymerase Epsilon Deficiency Causes IMAGe Syndrome with Variable Immunodeficiency.; American journal of human genetics; (2018).

  • <i>PCNT</i> point mutations and familial intracranial aneurysms.; Neurology; (2018).

  • Oro-dental and cranio-facial characteristics of osteogenesis imperfecta type V.; European journal of medical genetics; (2018).

  • GGC Repeat Expansion and Exon 1 Methylation of XYLT1 Is a Common Pathogenic Variant in Baratela-Scott Syndrome.; American journal of human genetics; (2018).

  • Multicenter study of mortality in achondroplasia.; American journal of medical genetics. Part A; (2018).

  • A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation.; American journal of human genetics; (2018).

  • Oral health-related quality of life in children and adolescents with osteogenesis imperfecta: cross-sectional study.; Orphanet journal of rare diseases; (2018).

  • A moderate form of osteogenesis imperfecta caused by compound heterozygous <i>LEPRE1</i> mutations.; Bone reports; (2018).

  • Mobility in Osteogenesis Imperfecta: A Multicenter North American Study; Unknown Source; (2018).

  • The expanding phenotype of RNU4ATAC pathogenic variants to Lowry Wood syndrome; American journal of medical genetics. Part A; (2018).

  • Growth characteristics in individuals with osteogenesis imperfecta in North America: results from a multicenter study; Genetics in medicine : official journal of the American College of Medical Genetics; (2018).

  • Best Practice Guidelines regarding Prenatal Evaluation and Delivery of Patients with Skeletal Dysplasia; American journal of obstetrics and gynecology; (2018).

  • Dental and facial characteristics of osteogenesis imperfecta type V; Unknown Source; (2018).

  • A multicenter study to evaluate pulmonary function in osteogenesis imperfecta.; Clinical genetics; (2018).

  • Microcephalic Osteodysplastic Primordial Dwarfism, Type II: a Clinical Review.; Current osteoporosis reports; (2017).

  • Mutations in DONSON disrupt replication fork stability and cause microcephalic dwarfism.; Nature genetics; (2017).

  • Corrigendum: Mutations in genes encoding condensins cause microcephaly through decatenation failure at mitosis.; Genes & development; (2017).

  • Re-alignment and intramedullary rodding of the humerus and forearm in children with osteogenesis imperfecta: revision rate and effect on fracture rate.; Journal of children's orthopaedics; (2017).

  • Metatropic dysplasia-a skeletal dysplasia with challenging airway and other anesthetic concerns.; Paediatric anaesthesia; (2017).

  • Cervical Spine Deformities in Children With Rhizomelic Chondrodysplasia Punctata.; Journal of pediatric orthopedics; (2017).

  • Arthroscopic knee anatomy in young achondroplasia patients.; Journal of children's orthopaedics; (2017).

  • Erratum to: Microcephalic Osteodysplastic Primordial Dwarfism, Type II: a Clinical Review.; Current osteoporosis reports; (2017).

  • Expected weight gain for children with microcephalic osteodysplastic primordial dwarfism type II.; American journal of medical genetics. Part A; (2017).

  • Best practices in peri-operative management of patients with skeletal dysplasias.; American journal of medical genetics. Part A; (2017).

  • Aneurysmal bone cysts and pathologic fracture associated with supernumerary ring chromosome 6 in two unrelated patients; American Journal of Medical Genetics Part A; (2017).

  • Growth charts for individuals with rhizomelic chondrodysplasia punctata.; Unknown Source; (2017).

  • Valgus Hip Osteotomy in Children With Spondyloepiphyseal Dysplasia Congenita: Midterm Results.; Unknown Source; (2017).

  • Arthroscopic Treatment of Discoid Lateral Meniscus Tears in Children With Achondroplasia.; Unknown Source; (2016).

  • Surgical outcomes of Majewski osteodysplastic primordial dwarfism Type II with intracranial vascular anomalies.; Unknown Source; (2016).

  • Response: "Best practices in the evaluation and treatment of foramen magnum stenosis in achondroplasia during infancy" and "Is there a correlation between sleep disordered breathing and foramen magnum stenosis in children with achondroplasia?".; Unknown Source; (2016).

  • Metatropic dysplasia is associated with increased fracture risk.; Unknown Source; (2016).

  • Mutations in genes encoding condensin complex proteins cause microcephaly through decatenation failure at mitosis.; Unknown Source; (2016).

  • TRAIP promotes DNA damage response during genome replication and is mutated in primordial dwarfism.; Unknown Source; (2016).

  • Magnetic resonance evaluation of the knee in children and adolescents with achondroplasia.; Unknown Source; (2015).

  • Non-invasive pulmonary function test on Morquio patients.; Unknown Source; (2015).

  • Congenital heart defects common in rhizomelic chondrodysplasia punctata.; Unknown Source; (2015).

  • Best practices in the evaluation and treatment of foramen magnum stenosis in achondroplasia during infancy.; Unknown Source; (2015).

  • Cesarean delivery is not associated with decreased at-birth fracture rates in osteogenesis imperfecta.; Unknown Source; (2015).

  • A mutation in TRPV4 results in altered chondrocyte calcium signaling in severe metatropic dysplasia.; Unknown Source; (2015).

  • Obstructive airway in Morquio A syndrome, the past, the present and the future.; Unknown Source; (2015).

  • Enzyme replacement therapy for treating mucopolysaccharidosis type IVA (Morquio A syndrome): effect and limitations.; Unknown Source; (2015).

  • Cartilage hair hypoplasia: characteristics and orthopaedic manifestations.; Unknown Source; (2015).

  • C-type natriuretic peptide plasma levels are elevated in subjects with achondroplasia, hypochondroplasia, and thanatophoric dysplasia.; Unknown Source; (2015).

  • Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome.; Unknown Source; (2015).

  • Multi-domain impact of elosufase alfa in Morquio A syndrome in the pivotal phase III trial.; Unknown Source; (2015).

  • Extreme growth failure is a common presentation of ligase IV deficiency.; Unknown Source; (2014).

  • Cervicothoracic myelopathy in children with Morquio syndrome A: a report of 4 cases.; Unknown Source; (2014).

  • Keutel syndrome: report of two novel MGP mutations and discussion of clinical overlap with arylsulfatase E deficiency and relapsing polychondritis.; Unknown Source; (2014).

  • 0041 Cross-sectional Multicenter Study of Osteogenesis Imperfecta in North America - Results from the Linked Clinical Research Centers.; Unknown Source; (2014).

  • Surgical treatment of scoliosis in osteogenesis imperfecta with cement-augmented pedicle screw instrumentation.; Unknown Source; (2014).

  • Jaffe-Campanacci syndrome, revisited: detailed clinical and molecular analyses determine whether patients have neurofibromatosis type 1, coincidental manifestations, or a distinct disorder.; Unknown Source; (2014).

  • Hip pathology in Majewski osteodysplastic primordial dwarfism type II.; Unknown Source; (2014).

  • A unique set of centrosome proteins requires pericentrin for spindle-pole localization and spindle orientation.; Unknown Source; (2014).

  • Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.; Unknown Source; (2013).

  • Flexion-extension cervical spine MRI in children with skeletal dysplasia: is it safe and effective?; Unknown Source; (2013).

  • Growth-sparing spinal instrumentation in skeletal dysplasia.; Unknown Source; (2013).

  • Growth in individuals with Majewski osteodysplastic primordial dwarfism type II caused by pericentrin mutations.; Unknown Source; (2012).

  • Meier-Gorlin syndrome genotype-phenotype studies: 35 individuals with pre-replication complex gene mutations and 10 without molecular diagnosis.; Unknown Source; (2012).

  • The lower extremity in Morquio syndrome.; Unknown Source; (2012).

  • Enzyme-replacement therapy in life-threatening hypophosphatasia.; Unknown Source; (2012).

  • A newly recognized syndrome with characteristic facial features, skeletal dysplasia, and developmental delay.; Unknown Source; (2012).

  • Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy.; Unknown Source; (2012).

  • Achondroplasia-hypochondroplasia complex and abnormal pulmonary anatomy.; Unknown Source; (2012).

  • Meier-Gorlin syndrome: growth and secondary sexual development of a microcephalic primordial dwarfism disorder.; Unknown Source; (2012).

  • Association of TALS developmental disorder with defect in minor splicing component U4atac snRNA.; Unknown Source; (2011).

  • Genetic defects in human pericentrin are associated with severe insulin resistance and diabetes.; Unknown Source; (2011).

  • Mutations in the pre-replication complex cause Meier-Gorlin syndrome.; Unknown Source; (2011).

  • Mutations in ORC1, encoding the largest subunit of the origin recognition complex, cause microcephalic primordial dwarfism resembling Meier-Gorlin syndrome.; Unknown Source; (2011).

  • Maternal mixed connective tissue disease and offspring with chondrodysplasia punctata.; Unknown Source; (2010).

  • Majewski osteodysplastic primordial dwarfism type II (MOPD II): expanding the vascular phenotype.; Unknown Source; (2010).

  • Fibrochondrogenesis results from mutations in the COL11A1 type XI collagen gene.; Unknown Source; (2010).

  • Expanding the phenotype of SPONASTRIME dysplasia to include short dental roots, hypogammaglobulinemia, and cataracts.; Unknown Source; (2008).

  • Clinical and molecular analysis of arylsulfatase E in patients with brachytelephalangic chondrodysplasia punctata.; Unknown Source; (2008).

  • Scott sign: a clinical measure of ligamentous laxity in achondroplastic infants.; Unknown Source; (2008).

  • Developing computational resources in cardiac gene expression.; Unknown Source; (2007).

  • The effect of intravenous pamidronate on bone mineral density, bone histomorphometry, and parameters of bone turnover in adults with type IA osteogenesis imperfecta.; Unknown Source; (2003).

  • CaGE: cardiac gene expression knowledgebase.; Unknown Source; (2002).

  • Chondrodysplasia Punctata 1, X-Linked; Unknown Source; (0000).

  • Hypochondroplasia; Unknown Source; (0000).

  • English